BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18648499)

  • 1. A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane.
    Martinez GQ; Maduke M
    PLoS One; 2008 Jul; 3(7):e2746. PubMed ID: 18648499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional severity of CLCNKB mutations correlates with phenotypes in patients with classic Bartter's syndrome.
    Cheng CJ; Lo YF; Chen JC; Huang CL; Lin SH
    J Physiol; 2017 Aug; 595(16):5573-5586. PubMed ID: 28555925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels.
    Gradogna A; Babini E; Picollo A; Pusch M
    J Gen Physiol; 2010 Sep; 136(3):311-23. PubMed ID: 20805576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and structural analysis of ClC-K chloride channels involved in renal disease.
    Waldegger S; Jentsch TJ
    J Biol Chem; 2000 Aug; 275(32):24527-33. PubMed ID: 10831588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and inhibition of kidney CLC-K chloride channels by fenamates.
    Liantonio A; Picollo A; Babini E; Carbonara G; Fracchiolla G; Loiodice F; Tortorella V; Pusch M; Camerino DC
    Mol Pharmacol; 2006 Jan; 69(1):165-73. PubMed ID: 16244177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology of renal chloride channels in Dent's disease and Bartter's syndrome.
    Thakker RV
    Exp Nephrol; 2000; 8(6):351-60. PubMed ID: 11014932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion.
    Estévez R; Boettger T; Stein V; Birkenhäger R; Otto E; Hildebrandt F; Jentsch TJ
    Nature; 2001 Nov; 414(6863):558-61. PubMed ID: 11734858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting a regulatory calcium-binding site of CLC-K kidney chloride channels.
    Gradogna A; Fenollar-Ferrer C; Forrest LR; Pusch M
    J Gen Physiol; 2012 Dec; 140(6):681-96. PubMed ID: 23148261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels.
    Zifarelli G; Liantonio A; Gradogna A; Picollo A; Gramegna G; De Bellis M; Murgia AR; Babini E; Camerino DC; Pusch M
    Br J Pharmacol; 2010 Aug; 160(7):1652-61. PubMed ID: 20649569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of differential pore blocking of kidney CLC-K chloride channels.
    Picollo A; Liantonio A; Didonna MP; Elia L; Camerino DC; Pusch M
    EMBO Rep; 2004 Jun; 5(6):584-9. PubMed ID: 15167890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of CLCNKB mutations at dimer-interface, calcium-binding site, and pore reveals a variety of functional alterations in ClC-Kb channel leading to Bartter syndrome.
    Bignon Y; Sakhi I; Bitam S; Bakouh N; Keck M; Frachon N; Paulais M; Planelles G; Teulon J; Andrini O
    Hum Mutat; 2020 Apr; 41(4):774-785. PubMed ID: 31803959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of CLC-Ka/barttin by the ubiquitin ligase Nedd4-2 and the serum- and glucocorticoid-dependent kinases.
    Embark HM; Böhmer C; Palmada M; Rajamanickam J; Wyatt AW; Wallisch S; Capasso G; Waldegger P; Seyberth HW; Waldegger S; Lang F
    Kidney Int; 2004 Nov; 66(5):1918-25. PubMed ID: 15496163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of CLC-0 chloride channels from separated transmembrane and cytoplasmic domains.
    Maduke M; Williams C; Miller C
    Biochemistry; 1998 Feb; 37(5):1315-21. PubMed ID: 9477958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of the cytoplasmic domain of the chloride channel ClC-Ka reveals a conserved interaction interface.
    Markovic S; Dutzler R
    Structure; 2007 Jun; 15(6):715-25. PubMed ID: 17562318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Insights into the Mechanism of NO
    Lagostena L; Zifarelli G; Picollo A
    J Am Soc Nephrol; 2019 Feb; 30(2):293-302. PubMed ID: 30635372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and functional analysis of novel mutations of the CLCNKB gene in Chinese patients with classic Bartter syndrome.
    Yu Y; Xu C; Pan X; Ren H; Wang W; Meng X; Huang F; Chen N
    Clin Genet; 2010 Feb; 77(2):155-62. PubMed ID: 19807735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis.
    Thakker RV
    Curr Opin Nephrol Hypertens; 1998 Jul; 7(4):385-8. PubMed ID: 9690036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CLC-KB gene promoter drives the EGFP expression in the specific distal nephron segments and inner ear.
    Kobayashi K; Uchida S; Okamura HO; Marumo F; Sasaki S
    J Am Soc Nephrol; 2002 Aug; 13(8):1992-8. PubMed ID: 12138129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salt-losing nephropathy in mice with a null mutation of the Clcnk2 gene.
    Grill A; Schießl IM; Gess B; Fremter K; Hammer A; Castrop H
    Acta Physiol (Oxf); 2016 Nov; 218(3):198-211. PubMed ID: 27421685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role and function of voltage-gated chloride channels of the CIC family and their defects leading to genetic diseases].
    Dołowy K; Bednarczyk P; Hordejuk R; Dworakowska B; Nurowska E; Jarzabek W
    Postepy Hig Med Dosw; 2002; 56(3):307-13. PubMed ID: 12194243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.